Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateSector Deep DivesUploadPipelinePE CyclesBrainAbout

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Momentum
  3. /Trading
  4. /Riddhi Siddhi Gluco Biols Ltd
MomentumDeep Value

Riddhi Siddhi Gluco Biols Ltd: Why Is It Outperforming Nifty 500?

Active
RS +65.5%Very WeakRe-Entry

In Week of Jun 27, 2026, Riddhi Siddhi Gluco Biols Ltd (Trading) is outperforming Nifty 500 with +65.5% relative strength. Fundamentals: Very Weak.

Riddhi Siddhi Gluco Biols Ltd Key Facts

PE Ratio
26.8x
Market Cap
₹533 Cr
PAT Growth YoY
-760%
Revenue Growth YoY
-68%
OPM
-89.0%
RS vs Nifty 500
+65.5%
PE: At PeakMomentum Only

What's Happening

📊PE near cycle highs — limited room for further expansion
💪Debt reduced 20% YoY — balance sheet strengthening
💰Trading 85% above estimated fair value — significant premium

Key Numbers

PAT Growth YoY
-760%
Stable
Revenue YoY
-68%
Inflection Down
Operating Margin
-89.0%
-7700 bps YoY
PE Ratio
26.8
Current Price
₹748
Dividend Yield
0.40%
Fundamental Score
18/100
Very Weak
3Y PAT CAGR
0%
Market Cap
533 Cr
Valuation
Significantly Overvalued

12-Week Performance

Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.

12 weeks agoThis week

How Fast Is Riddhi Siddhi Gluco Biols Ltd Growing?

Revenue, profit and margin growth rates

MetricYoY3Y CAGRTrend
Revenue-68%+11%Inflection Down
PAT (Net Profit)-760%0%Stable
OPM-89.0%-7700 bpsVolatile

Other Top Trading Stocks Beating Nifty 500

Adani Enterprises Ltd
Very Weak • 9w streak
+53.4%
Lloyds Enterprises Ltd
Average
+57.3%
MMTC Ltd
Weak
+12.8%
SG Mart Ltd
Average • 12w streak
+13.9%
Rashi Peripherals Ltd
Average • 12w streak
+109.0%
← Back to TradingDashboard

Frequently Asked Questions: Riddhi Siddhi Gluco Biols Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Riddhi Siddhi Gluco Biols Ltd's latest quarterly results?

Riddhi Siddhi Gluco Biols Ltd's latest quarterly results (Mar 2026) show

  • PAT Growth YoY: -760.0% (stable)
  • Revenue Growth YoY: -67.9%
  • Operating Margin: -89.0% (volatile)

Is Riddhi Siddhi Gluco Biols Ltd's profit growing or declining?

Riddhi Siddhi Gluco Biols Ltd's profit is declining with an stable trend.

  • PAT Growth YoY: -760.0% (latest quarter)
  • PAT Growth QoQ: -3200.0% (sequential)
  • 3-Year PAT CAGR: 0.0%
  • Trend: Stable — consistent growth pattern

What is Riddhi Siddhi Gluco Biols Ltd's revenue growth trend?

Riddhi Siddhi Gluco Biols Ltd's revenue growth trend is inflecting downward.

  • Revenue Growth YoY: -67.9%
  • Revenue Growth QoQ: -77.5% (sequential)
  • 3-Year Revenue CAGR: +10.9%

How is Riddhi Siddhi Gluco Biols Ltd's operating margin trending?

Riddhi Siddhi Gluco Biols Ltd's operating margin is volatile.

  • Current OPM: -89.0%
  • OPM Change YoY: -77.0% basis points
  • OPM Change QoQ: -75.0% basis points

What is Riddhi Siddhi Gluco Biols Ltd's 3-year profit and revenue CAGR?

Riddhi Siddhi Gluco Biols Ltd's long-term compounding rates

  • 3-Year Profit CAGR: 0.0%
  • 3-Year Revenue CAGR: +10.9%

Is Riddhi Siddhi Gluco Biols Ltd's growth accelerating or decelerating?

Riddhi Siddhi Gluco Biols Ltd's earnings growth is stable with mixed signals on a sequential basis.

  • YoY Acceleration: -178.1% bps
  • Sequential Acceleration: 0.0% bps
  • Margin Warning: Operating margins are under pressure

What is Riddhi Siddhi Gluco Biols Ltd's trailing twelve month (TTM) performance?

Riddhi Siddhi Gluco Biols Ltd's trailing twelve month (TTM) performance

  • TTM PAT: ₹-12 Cr
  • TTM PAT Growth: 0.0% YoY
  • TTM Revenue: ₹236 Cr
  • TTM Revenue Growth: +74.8% YoY
  • TTM Operating Margin: -5.1%

Is Riddhi Siddhi Gluco Biols Ltd overvalued or undervalued?

Riddhi Siddhi Gluco Biols Ltd appears significantly overvalued based on our fair value analysis.

  • Valuation Signal: Significantly Overvalued
  • Current PE: 26.8x
  • Price-to-Book: 0.3x

What is Riddhi Siddhi Gluco Biols Ltd's current PE ratio?

Riddhi Siddhi Gluco Biols Ltd's current PE ratio is 26.8x.

  • Current PE: 26.8x
  • Market Cap: 533 Cr
  • Dividend Yield: 0.40%

How does Riddhi Siddhi Gluco Biols Ltd's valuation compare to its history?

Riddhi Siddhi Gluco Biols Ltd's current PE is 26.8x.

  • Current PE: 26.8x
  • Valuation Assessment: Significantly Overvalued

What is Riddhi Siddhi Gluco Biols Ltd's price-to-book ratio?

Riddhi Siddhi Gluco Biols Ltd's price-to-book ratio is 0.3x.

  • Price-to-Book (P/B): 0.3x
  • Book Value per Share: ₹2117
  • Current Price: ₹748

Is Riddhi Siddhi Gluco Biols Ltd a fundamentally strong company?

Riddhi Siddhi Gluco Biols Ltd is rated Very Weak with a fundamental score of 18/100. This score is calculated from objective financial metrics

  • Revenue Growth YoY: -67.9% (10% weight)
  • PAT Growth YoY: -760.0% (10% weight)
  • PAT Growth QoQ: -3200.0% (10% weight)
  • Margins stable (10% weight)

Is Riddhi Siddhi Gluco Biols Ltd debt free?

Riddhi Siddhi Gluco Biols Ltd has a debt-to-equity ratio of N/A.

  • Total Debt: ₹283 Cr

What is Riddhi Siddhi Gluco Biols Ltd's return on equity (ROE) and ROCE?

Riddhi Siddhi Gluco Biols Ltd's return ratios over recent years

  • FY2024: ROCE 5.0%
  • FY2025: ROCE 5.0%
  • FY2026: ROCE 3.0%

Is Riddhi Siddhi Gluco Biols Ltd's cash flow positive?

Riddhi Siddhi Gluco Biols Ltd's operating cash flow is negative (FY2026).

  • Cash from Operations (CFO): ₹-9 Cr
  • Free Cash Flow (FCF): ₹-31 Cr

What is Riddhi Siddhi Gluco Biols Ltd's dividend yield?

Riddhi Siddhi Gluco Biols Ltd's current dividend yield is 0.40%.

  • Dividend Yield: 0.40%
  • Current Price: ₹748

Who holds Riddhi Siddhi Gluco Biols Ltd shares — promoters, FII, DII?

Riddhi Siddhi Gluco Biols Ltd's shareholding pattern (Jun 2026)

  • Promoters: 75.0%
  • FII (Foreign): 2.7%
  • DII (Domestic): 0.0%
  • Public: 22.3%

Is promoter holding increasing or decreasing in Riddhi Siddhi Gluco Biols Ltd?

Riddhi Siddhi Gluco Biols Ltd's promoter holding has decreased recently.

  • Current Promoter Holding: 75.0% (Jun 2026)
  • Previous Quarter: 86.5% (Mar 2026)
  • Change: -11.55% (decreasing — worth monitoring)

How long has Riddhi Siddhi Gluco Biols Ltd been outperforming Nifty 500?

Riddhi Siddhi Gluco Biols Ltd has been outperforming Nifty 500 for 3 consecutive weeks, indicating early-stage outperformance.

Is Riddhi Siddhi Gluco Biols Ltd a new momentum entry or an established outperformer?

Riddhi Siddhi Gluco Biols Ltd is a re-entry — it briefly dropped off the outperformance list but has now returned. Re-entries can signal renewed strength.

Is Riddhi Siddhi Gluco Biols Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Riddhi Siddhi Gluco Biols Ltd may be worth studying

  • Currently showing mixed signals — monitor for clearer trend confirmation

What is the investment thesis for Riddhi Siddhi Gluco Biols Ltd?

Riddhi Siddhi Gluco Biols Ltd investment thesis summary:

Risk Factors (Bear Case)

  • Margins under pressure
  • Appears significantly overvalued

What is the future outlook for Riddhi Siddhi Gluco Biols Ltd?

Riddhi Siddhi Gluco Biols Ltd's forward outlook based on current data signals

  • Earnings Trend: stable
  • Revenue Trend: inflecting downward
  • Margin Trend: volatile
  • Valuation: Significantly Overvalued

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.